TickerFactsScreenerDevelopers

KalVista Pharmaceuticals, Inc. (KALV) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $18.0K2014: $159.0K2015: $659.0K2016: $11.0K2017: $74.0K2018: $1.43M2019: $1.08M2020: $220.0K2021: $82.0K2022: $931.0K2023: $1.20M2024: $42.0K2025: $434.0K$434.0K
2013Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$434.0K+933.3%
2024$42.0K-96.5%
2023$1.20M+28.5%
2022$931.0K+1035.4%
2021$82.0K-62.7%
2020$220.0K-79.6%
2019$1.08M-24.2%
2018$1.43M+1828.4%
2017$74.0K+572.7%
2016$11.0K-98.3%
2015$659.0K+314.5%
2014$159.0K+783.3%
2013$18.0K—